ArriVent BioPharma, Inc. (AVBP)

Latest Insider Confidence Score

2026Q1

47.6
Bearish

Company insider confidence (by quarter)

2024Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Healy James Director 1,252,308 Jan 31, 2024
Yao Zhengbin — 613,138 Jan 25, 2024
LaChapelle Robin — 491,494 Jan 25, 2024
Orbimed Advisors Llc Director 469,615 Jan 31, 2024
OrbiMed Capital GP VIII LLC Director 469,615 Jan 31, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 2, 2026 Feb 4, 2026 LaChapelle Robin COO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Lutzker Stuart President Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Kung Winston CFO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Yao Zhengbin CEO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Kastenmayer James Paul General Counsel Neutral 52.5 - 0.00% ✗ -
Dec 10, 2025 Feb 3, 2026 HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% Owner Sell 15.0 -555,555 -12.39% ✗ $13M
Jul 11, 2025 Jul 15, 2025 LaChapelle Robin COO Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 Parsey Merdad Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 Peterson Kristine Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
Jun 18, 2025 Jun 20, 2025 Nolet Chris Director Neutral 52.5 - 0.00% ✗ -
Apr 28, 2025 Apr 29, 2025 Parsey Merdad Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2025 Parsey Merdad Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 14, 2025 Yao Zhengbin CEO Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 14, 2025 Lutzker Stuart President Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 14, 2025 LaChapelle Robin COO Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 14, 2025 Kung Winston CFO Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 14, 2025 Kastenmayer James Paul General Counsel Neutral 52.5 - 0.00% ✗ -
Sep 19, 2024 Sep 23, 2024 LaChapelle Robin COO Neutral 52.5 - 0.00% ✗ -
May 16, 2024 May 20, 2024 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
May 20, 2024 Hohneker John Director Neutral 52.5 - 0.00% ✗ -
Apr 22, 2024 Apr 23, 2024 Peterson Kristine Director Neutral 52.5 - 0.00% ✗ -
Apr 23, 2024 Peterson Kristine Director Neutral 52.5 - 0.00% ✗ -
Jan 30, 2024 Feb 1, 2024 HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% Owner Buy 100.0 +555,555 14.14% ✗ $10M
Jan 30, 2024 Jan 31, 2024 ORBIMED ADVISORS LLC Director Buy 100.0 +444,444 17.21% ✗ $8M
Jan 30, 2024 Jan 31, 2024 GORDON CARL L Director Buy 100.0 +444,444 17.21% ✗ $8M
Jan 30, 2024 Jan 31, 2024 HEALY JAMES Director Buy 100.0 +444,444 35.49% ✗ $8M
Jan 25, 2024 Jan 29, 2024 Nolet Chris Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 Jan 29, 2024 Jallal Bahija Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 ORBIMED ADVISORS LLC Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 Yao Zhengbin CEO Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 Nolet Chris Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 Lutzker Stuart President Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 LaChapelle Robin COO Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 Kung Winston CFO Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 Kastenmayer James Paul General Counsel Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 HEALY JAMES Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 GORDON CARL L Director Neutral 52.5 - 0.00% ✗ -
Jan 25, 2024 Jallal Bahija Director Neutral 52.5 - 0.00% ✗ -